Diagnosis

  • MedTech Companies Paxman and Dignitana Announce Merger

    Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new chapter of working together to advance side effect management for cancer patients around the world. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB [...]

  • New endometriosis pill on the NHS could benefit more than 1,000 women a year

    A new daily pill for endometriosis has been approved for use on the NHS and could help over a thousand women in England every year manage the symptoms of the debilitating condition. The once-a-day pill, linzagolix, will soon be available for NNewHS patients in England who have had previous treatment for endometriosis, following approval by [...]

  • FT Awards menopause

    Women with endometriosis face significantly higher risk of early menopause Women with endometriosis are seven times more likely to undergo surgical menopause and face increased risks of premature menopause, according to a major international study. The research, which analysed data spanning nearly 30 years, highlights a clear link between the inflammatory condition and early reproductive [...]

  • FDA de novo authorisation for first-ever OTC PCR test for women’s sexual health

    Diagnostics company Visby Medical has been granted De Novo authorisation for the Visby Medical Women's Sexual Health Test by the U.S. Food and Drug Administration (FDA) for Over the Counter (OTC) use. The groundbreaking test enables rapid and private at-home testing for chlamydia, gonorrhea, and trichomoniasis — the three most common curable sexually transmitted infections [...]

  • Breakthrough AI solution to advance early detection in women’s health

    Covera Health has announced the launch of Protect Her - an AI-powered solution designed to enhance early detection of critical health conditions predominantly impacting women ages 40 and up. Protect Her utilises latest advances in radiology AI to identify early signs of breast cancer, cardiovascular disease and osteoporosis during routine scans that women are already [...]

  • AI-powered mammograms: a new window into heart health

    Mammograms used in combination with AI may reveal much more than cancer,  but can also be used to assess the amount of calcium build up in the arteries within breast tissue - an indicator of cardiovascular health, a new study shows. While breast artery calcifications can be seen on mammogram images, radiologists do not typically [...]

  • Breast cancer screening catches more than 60,000 cases, but uptake declining

    Screenings for breast cancer in the UK have caught more than 60,000 cases, however, participation in cancer screening is struggling to return to pre-Covid levels.  In England, breast cancer screenings are conducted to help prevent cancer or catch cancer at early stage. The new insights from Cancer Research UK reveal that from 2019 to 2023, [...]

  • World-first at-home test delivers more accurate gestational diabetes diagnoses

    Standard NHS procedures for processing gestational diabetes blood sugar tests lead to more than 50 per cent of cases being missed, shows research, which could lead to serious complications for mothers. Such complications include the development of preeclampsia, and for the baby an increased risk of admission to the Neonatal Intensive Care Unit for breathing [...]

  • Women pay for AI to boost mammogram findings

    More than a third of women across 10 health care practices in the US chose to enrol in a self-pay, artificial intelligence (AI)-enhanced breast cancer screening programme, and the women who enrolled were 21 per cent more likely to have cancer detected, according to new research. AI has shown great promise in mammography as a [...]

  • New mammography system designed to enhance screening unveiled

    A new mammography system has been unveiled which has been designed to provide mammography technologists with a suite of tools that balance the demands of diagnostic accuracy and fast-paced workflows to facilitate more patient-centred breast care. Developed by GE HealthCare, the Pristina Via mammography system aims to minimise repetitive tasks and streamline workflows so that [...]